AlloVir, Inc. (ALVR) Financials
ALVR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 190.8 million | 45.0 million |
2023-09-30 | 248.3 million | 53.0 million |
2023-06-30 | 282.7 million | 53.6 million |
2023-03-31 | 244.0 million | 50.5 million |
ALVR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -30.7 million | 10.0 million |
2023-09-30 | -34.5 million | 10.5 million |
2023-06-30 | -27.1 million | 10.3 million |
2023-03-31 | -32.1 million | 10.0 million |
ALVR Net Income
No data available :(
ALVR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 183.9 million | - | 27.4 million |
2023-09-30 | 213.3 million | - | 32.9 million |
2023-06-30 | 246.5 million | - | 31.5 million |
2023-03-31 | 202.6 million | - | 33.8 million |
ALVR Shares Outstanding
ALVR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 33.2 million | 10.5 million | - |
2023-09-30 | - | 34.2 million | 12.8 million | - |
2023-06-30 | - | 31.3 million | 16.0 million | - |
2023-03-31 | - | 30.7 million | 12.5 million | - |
ALVR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 141000 |
2023-09-30 | - | 3.6 million |
2023-06-30 | - | - |
2023-03-31 | - | 547000 |
ALVR
Price: $0.80
52 week price:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 86807
Market Capitalization: 85.8 million